THI Grand Rounds | Robert E. Gerszten, MD | Multi-omic Profiling of Humans: Big Data, Big Promises, Small Results

Robert E. Gerszten, MD
Chief , Division of Cardiovascular Medicine
Beth Israel Deaconess Medical Center
Herman Dana Professor of Medicine at Harvard Medical School
Senior Associate Member of the Broad Institute

Robert E. Gerszten, MD is Chief of Cardiology at Beth Israel Deaconess Medical Center, the Herman Dana Professor of Medicine at Harvard Medical School, and a Senior Associate Member of the Broad Institute.  Dr. Gerszten graduated from the Johns Hopkins University School of Medicine. He completed his residency at the Hospital of the University of Pennsylvania and a clinical fellowship in cardiology at Massachusetts General Hospital (MGH). He also performed research fellowships at the Cardiovascular Research Institute at the University of California, San Francisco and the Cardiovascular Research Center at MGH.

Dr. Gerszten’s investigations focus on the nexus of cardiac and metabolic diseases.  His translational research program leverages metabolomics and proteomic technologies for the discovery of new biomarkers and pathways contributing to atherogenesis and its complications.  His highly interactive program collaborates across a spectrum of institutions, from the Broad Institute to the Framingham Heart Study, the Jackson Heart Study, the Diabetes Prevention Program, and the TIMI Study Group.

His work has been funded by the NIH and the American Heart Association, from whom he received an Established Investigator Award.  Dr. Gerszten is a member of the American Society for Clinical Investigation, the Association of American Physicians, and the Association of University Cardiologists.